Anton N Chikaev

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Venues

Vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Pavel P Solodkov, Alexander M Najakshin, Nikolai A Chikaev, Sergey V Kulemzin, Ludmila V Mechetina, Konstantin O Baranov, Sergey V Guselnikov, Andrey A Gorchakov, Tatyana N Belovezhets, Anton N Chikaev, Olga Y Volkova, Alexander G Markhaev, Yulia V Kononova, Alexander Yu Alekseev, Marina A Gulyaeva, Alexander M Shestopalov, Alexander V Taranin
Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies. Vaccines 12 (2) (2024)
Sergey V Kulemzin, Sergey V Guselnikov, Boris G Nekrasov, Svetlana V Molodykh, Irina N Kuvshinova, Svetlana V Murasheva, Tatyana N Belovezhets, Andrey A Gorchakov, Anton N Chikaev, Nikolai A Chikaev, Olga Y Volkova, Anna A Yurina, Alexander M Najakshin, Alexander V Taranin
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection. Vaccines 12 (1) (2024)
Sergey V Kulemzin, Sergey V Guselnikov, Boris G Nekrasov, Svetlana V Molodykh, Irina N Kuvshinova, Svetlana V Murasheva, Tatyana N Belovezhets, Andrey A Gorchakov, Anton N Chikaev, Nikolai A Chikaev, Olga Y Volkova, Anna A Yurina, Alexander M Najakshin, Alexander V Taranin
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection. Vaccines 12 (1) (2024)
Pavel P Solodkov, Alexander M Najakshin, Nikolai A Chikaev, Sergey V Kulemzin, Ludmila V Mechetina, Konstantin O Baranov, Sergey V Guselnikov, Andrey A Gorchakov, Tatyana N Belovezhets, Anton N Chikaev, Olga Y Volkova, Alexander G Markhaev, Yulia V Kononova, Alexander Yu Alekseev, Marina A Gulyaeva, Alexander M Shestopalov, Alexander V Taranin
Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies. Vaccines 12 (2) (2024)
Sergey V Kulemzin, Sergey V Guselnikov, Boris G Nekrasov, Svetlana V Molodykh, Irina N Kuvshinova, Svetlana V Murasheva, Tatyana N Belovezhets, Andrey A Gorchakov, Anton N Chikaev, Nikolai A Chikaev, Olga Y Volkova, Anna A Yurina, Alexander M Najakshin, Alexander V Taranin
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection. Vaccines 12 (1) (2024)
Iuliia A Merkuleva, Dmitriy N Shcherbakov, Mariya B Borgoyakova, Daniil V Shanshin, Andrey P Rudometov, Larisa Ivanovna Karpenko, Svetlana V Belenkaya, Anastasiya A Isaeva, Valentina S Nesmeyanova, Elena I Kazachinskaia, Ekaterina A Volosnikova, Tatiana I Esina, Anna V Zaykovskaya, Oleg V Pyankov, Sophia S Borisevich, Arseniya A Shelemba, Anton N Chikaev, Alexander A Ilyichev
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems. Vaccines 10 (1) (2022)
Ekaterina V Starostina, Sergei V Sharabrin, Denis N Antropov, Grigory A Stepanov, Georgiy Yu Shevelev, Anna E Lemza, Andrey P Rudometov, Mariya B Borgoyakova, Nadezhda B Rudometova, Vasiliy Yu Marchenko, Natalia V Danilchenko, Anton N Chikaev, Sergei I Bazhan, Alexander A Ilyichev, Larisa Ivanovna Karpenko
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens. Vaccines 9 (5) (2021)

Anton N Chikaev.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anton N Chikaev